NASDAQ:MXL

MaxLinear (MXL) Q1 Earnings: Strong Revenue Growth Outshines EPS Miss

Font: Financial Modeling Prep  • Apr 23, 2026

Market Chart

MaxLinear (NASDAQ: MXL) Q1 Earnings: Revenue Growth Outshines EPS Miss

MaxLinear reported strong Q1 revenue of $137.19 million, surpassing analyst expectations and demonstrating significant year-over-year growth.
Despite revenue strength, the company posted an earnings per share (EPS) of -$0.52, missing forecasts and resulting in a negative P/E ratio of -22.71.
The company maintains a healthy financial position with a low debt-to-equity ratio of 0.28 and a robust current ratio of 1.70, indicating strong liquidity.

MaxLinear, Inc. (NASDAQ: MXL) is a company that creates semiconductor products for communications. Its innovative technology is widely used in data centers, broadband access, and industrial markets. Following its first-quarter earnings release, MaxLinear's stock experienced a notable increase, as highlighted by Benzinga, even with mixed financial results reported to the market.

On April 23, 2026, the company announced its quarterly revenue was $137.19 million, beating the consensus estimate of $134.56 million. As reported by Businesswire, this revenue marks a 1% increase from the previous quarter. It also shows a significant 43% rise compared to the same quarter one year ago, indicating strong revenue growth.

Despite the strong revenue, MaxLinear posted an earnings per share (EPS) of -$0.52, which missed the analyst forecast of $0.18. This loss is tied to its GAAP operating expenses of $96.10 million for the quarter. This resulted in a GAAP loss from operations that was 13% of its net revenue.

Because the company is not currently profitable, it has a negative price-to-earnings (P/E) ratio of -22.71. A negative P/E ratio happens when a company has negative earnings, or a net loss. Investors also observe the company's price-to-sales ratio, a key stock valuation metric, which stands at 6.03, comparing its stock price to its revenues.

Looking at its financial health, MaxLinear has a debt-to-equity ratio of 0.28, which indicates the company has low debt relative to its shareholder equity. Furthermore, its current ratio of 1.70 suggests a solid capacity to meet its short-term obligations, as its current assets are 1.70 times its current liabilities, highlighting strong liquidity.

Market Overview
CTNT
Cheetah Net Supply Chain Service Inc.
$0.04
28.40%
INTC
Intel Corporation
$82.54
23.60%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$13.52
-13.86%
NVDA
NVIDIA Corporation
$208.27
4.32%
SCNI
Scinai Immunotherapeutics Ltd.
$0.74
61.62%
TZA
Direxion Daily Small Cap Bear 3X ETF
$5.04
-0.98%
NOK
Nokia Oyj
$10.46
1.21%
BYND
Beyond Meat, Inc.
$0.87
-8.07%
CHSN
Chanson International Holding
$0.18
-92.62%
TSLL
Direxion Daily TSLA Bull 2X ETF
$12.17
1.25%